“Ping” is slang for MDMA, the psychoactive compound most people know as ecstasy or molly. The term is common in Australian and British club culture, referring to the rush of euphoria and heightened connection users feel after taking the drug. MDMA sits in a unique pharmacological category sometimes called “entactogens,” meaning it produces feelings of emotional closeness and empathy that set it apart from straightforward stimulants or classic psychedelics. Understanding what happens in your body when you take a ping, and what can go wrong, requires looking at both the chemistry and the real-world conditions in which people use it.
How MDMA Works in the Brain
MDMA’s effects come from the way it floods your brain with certain chemical messengers. It primarily forces the release of serotonin, the neurotransmitter tied to mood, trust, and emotional bonding, but it also pushes out dopamine and norepinephrine. Research in mice confirmed that MDMA acts on both the serotonin transporter and the dopamine transporter to boost levels of both chemicals in the brain.1PubMed Central. Effects of MDMA on Extracellular Dopamine and Serotonin Levels in Mice Lacking Dopamine and/or Serotonin Transporters The serotonin surge is what produces the emotional warmth and empathy people describe, while the dopamine and norepinephrine contribute to the stimulant-like energy and alertness.
MDMA also triggers the release of oxytocin, a hormone associated with bonding and social trust. A controlled human study found that a single dose of MDMA raised plasma levels of oxytocin alongside cortisol and prolactin, and that these hormonal shifts corresponded with increases in emotional empathy and prosocial behavior.2PubMed Central. MDMA enhances emotional empathy and prosocial behavior This combination of serotonin flooding and oxytocin release is why MDMA’s effects feel so different from taking a standard amphetamine. In 1986, the pharmacologist David Nichols proposed the term “entactogen” specifically to describe MDMA and chemically similar drugs, distinguishing them from stimulants and hallucinogens.3PubMed Central. Entactogens: How the Name for a Novel Class of Psychoactive Agents Originated
What a Ping Feels Like
The subjective experience of MDMA blurs the line between stimulant and psychedelic. In a controlled study where moderate users received MDMA, participants reported effects consistent with both categories: stimulant-like feelings of elation and energy alongside changes on hallucinogenic rating scales that measure altered perception.4PubMed. The subjective effects of MDMA and mCPP in moderate MDMA users Users commonly describe a “come up” period about 30 to 45 minutes after swallowing a pill or capsule, followed by a plateau of heightened sensory pleasure, feelings of closeness with others, and reduced social anxiety that lasts roughly three to four hours.
The prosocial effects can be intense. Research on entactogens suggests that the combined pharmacological and hormonal shifts can recreate the subjective experience of emotional intimacy, or even mimic the feeling of falling in love with people who were previously neutral to the user.5PubMed Central. Can research on entactogens contribute to a deeper understanding of human sexuality? This is what draws many people to MDMA at music festivals and clubs, but it is also what makes the drug interesting to therapists treating conditions like PTSD, where emotional walls are part of the problem.
Physical Effects and the Cardiovascular Load
The mental effects of a ping get most of the attention, but what MDMA does to your body is where the immediate danger lies. The drug raises blood pressure and heart rate through its action on the norepinephrine system. Animal studies have shown that MDMA and its close chemical relatives produce a prolonged increase in both systolic and diastolic blood pressure, driven at least partly by stimulation of alpha-adrenergic receptors, the same receptors that tighten blood vessels during a fight-or-flight response.6PubMed Central. Effects of MDMA, MDA and MDEA on blood pressure, heart rate, locomotor activity and body temperature in the rat involve alpha-adrenoceptors For a healthy young adult with no heart conditions, this cardiovascular bump is usually temporary. For someone with an undiagnosed heart condition, it can be dangerous.
Other common physical effects include jaw clenching, teeth grinding (bruxism), dilated pupils, dry mouth, and muscle tension. Appetite drops. Nausea sometimes accompanies the come-up phase. These are all downstream consequences of the neurotransmitter surge, and while they are uncomfortable, they are not the effects that send people to the emergency room.
Hyperthermia and Why Environment Matters
The most life-threatening acute risk of MDMA is a dangerous rise in body temperature, and the setting where you take the drug plays a critical role. In clinical studies, MDMA raised core body temperature compared to placebo, and researchers found this was linked to an increase in metabolic rate.7PubMed Central. Effects of MDMA on body temperature in humans But the environment amplifies or buffers this effect dramatically. Animal research showed that the same dose of MDMA that caused hyperthermia at a normal room temperature actually produced a drop in body temperature in rats kept in a cool environment.8PubMed. Effect of ambient temperature on hyperthermia and hyperkinesis induced by 3,4-methylenedioxymethamphetamine (MDMA or “ecstasy”) in rats Even brief exposure to a cool environment significantly blunted the hyperthermic response.
This is why most MDMA-related medical emergencies happen in hot, crowded venues where people are dancing for hours. The drug revs up your internal heat production while also impairing your body’s ability to cool itself. Serotonin plays a role in normal thermoregulation, and when that system gets overwhelmed, the usual safety valve stops working. Research has shown that reducing serotonin function through various methods actually worsened MDMA-induced hyperthermia in rats housed at high ambient temperatures, suggesting that once the serotonin system is disrupted, the body loses an important cooling mechanism.9PubMed. The role of 5-HT in the impairment of thermoregulation observed in rats administered MDMA (‘ecstasy’) when housed at high ambient temperature In a packed nightclub with poor ventilation, this can escalate into heatstroke, organ damage, and death.
Hyponatremia and the Water-Drinking Myth
One of the crueler ironies of MDMA harm reduction messaging is that telling people to “drink water” has itself caused fatalities. MDMA triggers the release of vasopressin (also called antidiuretic hormone), which tells your kidneys to retain water. Research has shown that MDMA increases activity in the brain’s vasopressin-producing neurons, and that combining MDMA with a large water load is sufficient to drop blood sodium to dangerously low levels.10Physiology. Central Basis For MDMA (ecstasy) Induced Hyponatremia When blood sodium falls below a certain threshold, the brain swells. This condition, called hyponatremia, can cause seizures, coma, and death.
The practical advice is not to avoid water entirely, but to sip moderately and not force large volumes. Electrolyte-containing drinks are preferable to plain water, and taking breaks from dancing to cool down reduces both the heat risk and the urge to over-drink. Women appear to be at higher risk for MDMA-induced hyponatremia, possibly because of interactions between vasopressin and estrogen, though the mechanism is not fully settled.
Why Small Dose Differences Can Have Outsized Effects
A feature of MDMA’s chemistry that many users do not realize is that its metabolism does not scale in a straightforward way with dose. Research in humans found that as the dose of MDMA increases, blood concentrations rise disproportionately, not in a predictable linear fashion. The enzyme responsible for breaking down MDMA appears to become saturated or inhibited at recreational doses, meaning a modest increase in the amount you take can translate into a much larger jump in how much active drug is circulating in your blood.11PubMed Central. Non-linear pharmacokinetics of MDMA (‘ecstasy’) in humans This held true across the population regardless of individual genetic differences in the enzyme involved.
This non-linear metabolism is one reason why re-dosing or “topping up” carries more risk than people assume. The second dose hits a body that is already struggling to clear the first one. Combined with the environmental factors described above, this pharmacological quirk makes the difference between a manageable experience and a medical emergency smaller than most users appreciate.
The Comedown and What Happens to Serotonin
The days following MDMA use are often described as a “comedown” or, more colorfully, “suicide Tuesday” (so named because the low mood tends to peak a couple of days after weekend use). This is a direct consequence of the serotonin flood: your brain’s supply has been depleted, and it takes time to rebuild. In animal studies, a high-dose MDMA regimen depleted serotonin in multiple brain regions by roughly half to two-thirds.12PubMed Central. Repeated exposure to MDMA provides neuroprotection against subsequent MDMA-induced serotonin depletion in brain Users commonly report low mood, irritability, difficulty concentrating, poor sleep, and reduced appetite during this period.
For most people who use MDMA occasionally, the comedown resolves within a week as serotonin stores replenish. The severity tends to correlate with dose, re-dosing, and how rundown the person already was. Adequate sleep, nutrition, and time are the only reliable remedies, despite a cottage industry of “recovery supplement” stacks marketed online.
Longer-Term Serotonin Changes
Whether MDMA causes lasting damage to the serotonin system in humans has been debated for decades. Brain imaging of female MDMA users who also used other drugs found that serotonin receptor binding was increased by roughly 16 to 21 percent across multiple brain regions compared to controls, and the amount of lifetime MDMA use predicted the degree of change.13JAMA Psychiatry. Evidence for Chronically Altered Serotonin Function in the Cerebral Cortex of Female 3,4-Methylenedioxymethamphetamine Polydrug Users This increase in receptor density is thought to be the brain’s attempt to compensate for reduced serotonin signaling, a pattern consistent with serotonergic damage. The duration of abstinence from MDMA did not appear to reverse these changes.
Animal data paints a more direct picture. PET imaging in primates treated with MDMA showed reduced serotonin transporter density even seven years after exposure, though the deficit was less severe than at the 18-month mark.14Journal of Nuclear Medicine. Long-Term Effects of “Ecstasy” Use on Serotonin Transporters of the Brain Investigated by PET Whether partial recovery eventually reaches completion, and whether occasional human use at lower doses produces the same kind of changes seen in heavily dosed animals, remain open questions. The honest read of the evidence is that heavy, repeated use carries a real risk of lasting serotonin system changes, while the picture for infrequent users is murkier.
Contamination and What Is Actually in a Pill
One of the biggest practical dangers of taking a ping has nothing to do with MDMA itself. Street ecstasy is frequently adulterated or outright substituted with other substances. Data from seized pills showed that in 2001, about 69 percent of ecstasy tablets contained pure MDMA. By 2007, that figure had dropped to just 3 percent.15SAGE Publications. Legal highs, PMMA and zombie panic: Real dangers of the lacing of ecstasy pills Common adulterants have included methamphetamine, caffeine, ketamine, and, most dangerously, PMA and PMMA, which are far more toxic than MDMA and have been linked to multiple deaths. Purity levels have fluctuated since then, and in more recent years pill testing services in some countries have reported higher MDMA content in some markets, but the overall lesson remains: you cannot know what is in a pill by looking at it.
Reagent testing kits are widely sold as a harm reduction tool, but their usefulness has limits. When researchers put common reagent kits (Marquis, Mecke, and Simon’s) to the test, the kits failed to distinguish pure MDMA from adulterated forms. They lacked both the sensitivity and specificity needed for reliable identification, and even experienced toxicologists produced false-positive results when using the unfamiliar procedure.16PubMed. Putting an Ecstasy test kit to the test: harm reduction or harm induction? A reagent kit can tell you that a substance probably belongs to the MDMA family, but it cannot tell you whether the dose is safe or whether dangerous adulterants are also present. Services that use gas chromatography or mass spectrometry, such as those at some European music festivals, provide far more reliable results.
Dangerous Drug Combinations
Because MDMA acts so powerfully on serotonin, combining it with other drugs that raise serotonin levels creates a risk of serotonin syndrome, a medical emergency characterized by agitation, rapid heart rate, high blood pressure, muscle rigidity, and, in severe cases, seizures and death. The interaction between MDMA and SSRI antidepressants is particularly worrying because SSRIs are so widely prescribed. The combination can cause a rapid, compounding rise in brain serotonin levels.17PubMed. Ecstasy use and serotonin syndrome: a neglected danger to adolescents and young adults prescribed selective serotonin reuptake inhibitors
An analysis of adverse event reports found 20 cases of serotonin syndrome involving MDMA in a federal database. None of those cases involved MDMA alone; every report included at least one additional drug. The most commonly co-reported drug classes were amphetamines, opioids, benzodiazepines, cannabis, and SSRIs.18PubMed Central. Reported Cases of Serotonin Syndrome in MDMA Users in FAERS Database MAO inhibitors posed the greatest pharmacological risk per case, though they appeared less frequently because fewer people take them. The practical takeaway is straightforward: if you are on an antidepressant, particularly an SSRI, SNRI, or MAO inhibitor, taking MDMA is genuinely dangerous in a way that goes beyond the usual risks of the drug.
Dependence and Addiction Potential
MDMA does not create dependence the way opioids or alcohol do, but dismissing its addiction potential entirely would be a mistake. A review of both animal and human evidence concluded that MDMA is a less potent reinforcer than many other drugs, meaning the biological pull to keep using is weaker. However, it does have dependence potential, and the pattern of dependence looks different from substances like alcohol or methamphetamine.19PubMed. Is ecstasy a drug of dependence? Psychological factors, such as craving the emotional experience or the social context of use, play a larger role than physical withdrawal symptoms. Some users report tolerance and withdrawal-like symptoms, but researchers have struggled to disentangle these from the normal post-use comedown.
Animal research adds a cautionary note. Rats that developed tolerance to MDMA’s stimulant effects went on to escalate their self-administered doses and showed strong cue-triggered drug-seeking behavior after a period of abstinence.20PubMed Central. Tolerance to the locomotor-activating effects of 3,4-methylenedioxymethamphetamine (MDMA) predicts escalation of MDMA self-administration and cue-induced reinstatement of MDMA seeking in rats This suggests that while MDMA may not hook most users the way heroin does, a subset of individuals who develop tolerance may be more vulnerable to a pattern of escalating use.
MDMA in a Therapeutic Context
The same properties that make MDMA popular recreationally have attracted serious clinical interest for treating PTSD. In a phase 3 randomized trial, MDMA-assisted therapy produced a substantially larger reduction in PTSD symptoms than therapy with a placebo, with a moderate-to-large effect size. Participants who received MDMA alongside psychotherapy saw their PTSD severity scores drop more than those who received therapy alone.21Nature Medicine. MDMA-assisted therapy for moderate to severe PTSD: a randomized, placebo-controlled phase 3 trial The rationale is that MDMA’s ability to reduce fear and defensiveness while enhancing emotional openness allows patients to revisit traumatic memories in a therapeutic setting without being overwhelmed.
Despite promising trial results, the U.S. FDA declined to approve MDMA-assisted therapy in 2024, citing concerns about trial methodology and the difficulty of blinding participants (people generally know whether they received MDMA or a placebo). The regulatory path forward remains uncertain. It is worth noting that the therapeutic setting is radically different from recreational use: doses are carefully controlled, sessions are supervised by trained therapists, the environment is calm and climate-controlled, and patients take the drug only a few times total. Extrapolating the safety profile from clinical trials to unsupervised use in nightclubs would be a mistake in either direction.
How the Drug Got Its Start
MDMA was first synthesized by the pharmaceutical company Merck in 1912, not as a recreational drug or even a medicine, but as a chemical intermediate in the quest for a blood-clotting agent. Merck’s chemists were trying to find a way around a competitor’s patent on the synthesis of hydrastinine, and MDMA appeared as a byproduct of their workaround. The company resynthesized the molecule a few times over the following decades for various purposes and ran animal experiments, but never discovered its psychoactive effects in humans.22Oxford Scholarship Online. The Early History of MDMA It wasn’t until the 1970s that the chemist Alexander Shulgin resynthesized it, tried it himself, and introduced it to therapists who began using it in psychotherapy sessions. The drug migrated into the club scene in the 1980s, was banned in the United States in 1985, and has existed in that tension between therapeutic promise and recreational risk ever since.